Evidence map›Paper›PMID 42233776›Full record

ReviewInternal medicine journal2026

A new era beckons in asthma: enhanced models of care, disease remission, artificial intelligence and consumer participation.

John Politis, Kerry Hancock, Jo A Douglass, Paul Leong, Philip Bardin

Abstract readReview
In one paragraph

Review in Internal medicine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

John PolitisMonash Lung and Sleep Allergy Immunology, Monash University and Hospital, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-3227-3508
Kerry HancockAllergy and Lung Health Unit, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
Jo A DouglassDepartment of Medicine, University of Melbourne (Royal Melbourne Hospital), Melbourne, Victoria, Australia.
Paul LeongMonash Lung and Sleep Allergy Immunology, Monash University and Hospital, Melbourne, Victoria, Australia.
Philip BardinMonash Lung and Sleep Allergy Immunology, Monash University and Hospital, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-9596-574X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The landscape of asthma management is undergoing significant transformation. This change is driven by several factors: deeper understanding of asthma pathophysiology, appreciation of the long-term harm of oral corticosteroids, biological treatments that dramatically improve patient outcomes with asthma remission becoming a realistic goal, and a focus on patient-centred care combined with the use of virtual health and artificial intelligence strategies. This Viewpoint provides a perspective on current dilemmas and then emphasises recent innovations that can provide solutions. If applied judiciously, these advances will enable healthcare professionals to improve outcomes for people with asthma.

Indexed as

Artificial IntelligenceAsthmaCommunity ParticipationDisease ManagementAnti-Asthmatic AgentsHumansPatient-Centered CareRemission InductionAnti-Asthmatic Agentsasthmaasthma remissionbiologic agentsconsumer participationmodels of caretype‐2 airways disease

Identifiers

PMID42233776
PMCPMC13547911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.